https://www.biomarin.com/contact-us/
Contact Us | BioMarin
Mar 13, 2025 - Find contact info for BioMarin medical information, product support, media inquiries, investor relations and more.
contact usbiomarin
https://www.biomarin.com/data-privacy-center/
Data Privacy Center | BioMarin
Mar 3, 2026 - Read our privacy notices and learn more about our commitment to fostering privacy compliance within our business.
data privacy centerbiomarin
https://www.biomarin.com/
BioMarin Pharmaceutical | Global Biotechnology Company
May 6, 2026 - BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare...
biomarin pharmaceuticalglobalbiotechnologycompany
https://hcp.biomarin.com/en-gb/achondroplasia/expert/contact-page17/
Contact p17 - BioMarin ACH DSE Expert HCP EN-GB
biomarinachdseexperthcp
https://medical.biomarin.com/en-us/achondroplasia/publications/
Achondroplasia Publications | BioMarin Medical
Jan 7, 2026 - Learn more about achondroplasia and BioMarin therapies
achondroplasiapublicationsbiomarinmedical
https://business.wapakdailynews.com/wapakdailynews/quote/detailedquote?Symbol=537%3A729021
User | wapakdailynews.com - BioMarin Pharmaceutical Inc. - Common Stock (Nasdaq:BMRN) Detailed...
View detailed stock data for BioMarin Pharmaceutical Inc. - Common Stock (Nasdaq:BMRN)
biomarin pharmaceuticalcommon stockuser
https://www.sintef.no/alle-ansatte/ansatt/hanne.hatlebrekke/
Hanne Hjelle Hatlebrekke - Fiskeri og ny biomarin industri - SINTEF Ocean AS - SINTEF
hannehjellefiskeriog
https://www.biomarin.com/news/
News | BioMarin
Mar 20, 2024 - Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.
newsbiomarin
https://www.fool.com/investing/2020/01/16/biomarin-considers-3-million-price-tag-for-new-hem.aspx
BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy | The Motley Fool
Jan 16, 2020 - If approved, Valrox could become the most expensive drug in the world.
https://www.biomarin.com/careers/fellowships/
Regulatory Affairs and R&D Postdoctoral Fellowships | BioMarin
regulatory affairspostdoctoral fellowshipsbiomarin
https://members.vabio.org/pharm/biomarin-pharmaceutical
BioMarin Pharmaceutical - Virginia Bio
biomarin pharmaceuticalvirginia
https://biomarin.hr/author/nalicboban/
nalicboban, Author at Biomarin
authorbiomarin
https://pku.biomarin.com/en-gb/recipes/sicilian-salad/
Sicilian Salad - BioMarin PKU DSE Patient EN-GB
siciliansaladbiomarinpkudse
https://clinicaltrials.biomarin.com/clinical-trial/study-of-rhasb-in-patients-with-mucopolysaccharidosis-vi/
Study of rhASB in Patients With Mucopolysaccharidosis VI - BioMarin Clinical Trials
in patientsstudy
https://www.reveliolabs.com/companies/biomarin-pharmaceutical/employees/
How many employees work at BioMarin Pharmaceutical? | Revelio Labs
BioMarin Pharmaceutical, Inc. has 3,566 employees as of December 2025. Explore headcount trends, salary data, geographic breakdown, and job postings powered by...
how manywork atbiomarin pharmaceuticalemployeeslabs
https://www.valuethemarkets.com/companies/biomarin-pharmaceutical-inc/profile
BioMarin Pharmaceutical Inc | Value The Markets
biomarin pharmaceuticalincvaluemarkets
https://portfoliopilot.com/explore/security-explorer/BMRN
BMRN BioMarin Pharmaceutical Inc. | Forecast & Risk Analysis
BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and...
biomarin pharmaceuticalincforecastriskanalysis
https://worldpompe.org/archive/460-biomarin-reports-promising-results-of-pompe-phase-12-trial/
BioMarin Reports Promising Results of Pompe Phase 1/2 Trial - International Pompe Association
Mar 20, 2013 - BioMarin Pharmaceutical Inc. announced results from POM-001, the Phase 1/2 trial for BMN-701, a fusion protein of insulin-like growth factor 2 and acid...
https://www.biomarin.com/company/board-of-directors/richard-a-meier/
Board of Directors: Richard A. Meier | BioMarin
May 22, 2025 - Read about BioMarin Board of Directors Chair Richard A. Meier.
board of directorsrichardmeierbiomarin
https://www.marinij.com/2026/04/26/biomarin-pauses-expansion-of-san-rafael-complex/
BioMarin pauses expansion of San Rafael complex
Apr 28, 2026 - The pharmaceutical company says it could be years before it resumes efforts to redevelop 999 Third St. with buildings for offices and labs.
san rafaelbiomarinpausesexpansioncomplex
https://www.webaward.org/winner/32490/biomarin-wins-2016-webaward-for-biomarin-careers.html
BioMarin wins 2016 WebAward for BioMarin Careers
BioMarin has won the Best Pharmaceuticals Website for BioMarin Careers in the 2016 WebAward Competition.
biomarinwinscareers
https://ipverse.greyb.com/unified-patent-court/cases/case-details/biomarin-pharmaceutical-vs-ascendis-pharma-growth-disorders--app-33004-2025
Biomarin Pharmaceutical vs. Ascendis Pharma - APP_33004/2025 - IP Verse
The case APP_33004/2025 was filed by the plaintiff Biomarin Pharmaceutical against the defendant Ascendis Pharma on 23 Jul, 2025.
biomarin pharmaceuticalvsascendisappip
https://www.pharmiweb.com/pwtoday-story/biomarin-announces-new-rd-and-business-development-leadership
BioMarin Announces New R&D and Business Development Leadership - PharmiWeb.com
r dbusiness developmentbiomarinannouncesnew
https://www.dcatvci.org/top-industry-news/sarepta-biomarin-settle-exon-skipping-patent-dispute/
Sarepta, BioMarin Settle Exon-Skipping Patent Dispute - DCAT Value Chain Insights
Sep 8, 2021 - Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, and...
exon skippingpatent disputevalue chainsareptabiomarin
https://www.biomarin.com/science/medicines/
Medicines | BioMarin
Apr 27, 2026 - BioMarin provides eight treatment options for people living with genetically defined conditions. Learn more about our medicines here.
medicinesbiomarin
https://www.biomarin.com/patients/
Patients | BioMarin
Apr 24, 2026 - Learn about BioMarin’s approach to patient advocacy and how our first operating principle – patients are counting on us – drives our sense of urgency and focus.
patientsbiomarin
https://www.fool.com/investing/general/2016/03/02/biomarin-ratchets-up-the-profitability-talk.aspx
BioMarin Pharmaceutical Inc. Ratchets Up the Profitability Talk | The Motley Fool
Mar 2, 2016 - Investors will have to wait until next year, though.
biomarin pharmaceuticalincratchetsprofitabilitytalk
https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2035605&key=amifampridine
News for Medical Sales Reps: BioMarin Names Jeff Ajer Senior Vice President, Chief Commercial...
https://www4.lead411.com/Gene_Park_23656305.html
Gene Park | BioMarin Pharmaceutical | Email, Senior Director, Program Management
Gene Parkis the Senior Director, Program Management of . Lead411's profile includes an email address, bmrn.com, linkedin, biography, etc
biomarin pharmaceuticalsenior directorgeneparkemail
https://gth-akademie.org/biomarin_pharmaceutical-logo-wine/
BioMarin_Pharmaceutical-Logo.wine | GTH Akademie
biomarin pharmaceuticallogowinegthakademie
https://business.times-online.com/times-online/quote/news?Symbol=NQ%3ABMRN&CurrentPage=11&ChannelType=NEWS
User | times-online.com - Latest News about BioMarin Pharmaceutical Inc. - Common Stock...
times onlinelatest news
https://theorg.com/org/biomarin-pharmaceutical/org-chart/patrice-lebrun
Patrice Lebrun - Senior Vice President - Commercial International at BioMarin Pharmaceutical | The...
Patrice Lebrun has extensive experience in the pharmaceutical industry, holding various leadership positions in companies such as BioMarin Pharmaceutical Inc.
senior vice presidentbiomarin pharmaceuticalpatricelebrun
https://www.biomarin.com/careers/jobs/?keyword=intern
Search our Jobs | BioMarin
Mar 19, 2026 - Learn more about career opportunities at BioMarin by searching openings to join our team.
search our jobsbiomarin
https://www.biopharmadive.com/news/biomarin-reports-cancer-case-in-hemophilia-gene-therapy-trial/631648/
BioMarin reports cancer case in hemophilia gene therapy trial | BioPharma Dive
The development comes three weeks after Roctavian was approved in Europe and ahead of a planned regulatory submission in the U.S. Drug regulators have not...
gene therapybiomarinreportscancercase
https://www.biomarin.com/news/stories/category/people-and-culture/
Stories: People and Culture | BioMarin Corporate
people and culturestoriesbiomarincorporate
https://clinicaltrials.biomarin.com/clinical-trial/a-clinical-trial-to-evaluate-safety-of-vosoritide-in-at-risk-infants-with-achondroplasia/
A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia - BioMarin...
https://clinicaltrials.biomarin.com/clinical-trial/bone-mineral-density-in-adults-with-hyperphenylalaninemia-on-kuvan-therapy/
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy - BioMarin Clinical...
bone mineral density
https://pku.biomarin.com/en-gb/liveunlimited/lal/
Lal - BioMarin Live Unlimited PKU EN-GB
live unlimitedlalbiomarinpkuen
https://druganalyst.com/BioMarin/Drugs
BioMarin Drug Sales & Forecasts - DRUGANALYST
drug salesbiomarinforecasts
https://druganalyst.com/BioMarin/Kuvan
Kuvan (sapropterin) - BioMarin Sales History and Forecasts - DRUGANALYST
sales historysapropterinbiomarinforecasts
https://www.pharmamanufacturing.com/industry-news/news/55039926/biomarin-announces-170-layoffs
BioMarin announces 170 layoffs | Pharma Manufacturing
biomarinannounceslayoffspharmamanufacturing
https://pharsight.greyb.com/company/biomarin-drug-patent-portfolio
Biomarin Drug Patent Portfolio
Explore the complete list of drugs in Biomarin's Drug Patent Portfolio, along with the list of patents protecting each drug.
biomarindrugpatentportfolio
https://www4.lead411.com/Ashley_Powne_23656056.html
Ashley Powne | BioMarin Pharmaceutical | Email, Sr. Director, SRDO Strategy & Operations
biomarin pharmaceuticalashleyemailsrdirector
https://altindex.com/ticker/bmrn/earnings
Biomarin Pharmaceutical (BMRN) Earnings Statistics 2026
Analyze Earnings for Biomarin Pharmaceutical and gain a competitive edge with unique and comprehensive information.
biomarin pharmaceuticalearningsstatistics
https://www.sintef.no/alle-ansatte/ansatt/bendik.toldnes/
Bendik Toldnes - Fiskeri og ny biomarin industri - SINTEF Ocean AS - SINTEF
fiskeriognybiomarinindustri
https://achondroplasia.biomarin.com/en-us/event/rising-love-in-katy/
Rising Love in Katy - BioMarin ACH DSE Patient EN-US
risinglovekatybiomarinach
https://www.biomarin.com/en-au/landing/
Home - BioMarin Australia
biomarinaustralia
https://www.accoes.com/project/biomarin-46-galli-usep-novato-ca/
BioMarin 46 Galli-USEP | Novato, CA - ACCO
BioMarin is a biopharmaceutical company specializing in gene therapy for rare diseases. Due to their continuous growth, the utility demand within their...
novato cabiomaringalliusepacco
https://pku.biomarin.com/en-us/upcoming-events/pku-community/
PKU community - BioMarin PKU DSE Patient EN-US
Sep 29, 2025 - Join our phenylketonuria (PKU) community on Facebook. Watch how others manage their PKU. PKU twitter. Build a circle of support with others who understand life...
pku communitybiomarindsepatientus
https://340breport.com/glaxosmithkline-exelan-and-biomarin-and-issue-340b-refunds/
GlaxoSmithKline, Exelan, and BioMarin Issue 340B Refunds - 340B Report
Dec 7, 2021 - Three drug manufacturers recently announced they are refunding 340B overpayments to covered entities, part of a growing number of companies that have disclosed...
glaxosmithklinebiomarinissuerefundsreport